| Chemotherapy in Treating Patients Who Have Hematologic Cancer (NCT00004047) | Daiichi Sankyo | 1999-06-01 |
| Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine (NCT00058799) | Baylor College of Medicine | 1999-06-01 |
| Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation (NCT00609739) | Masonic Cancer Center, University of Minnesota | 1999-06-01 |
| Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia (NCT00005802) | Fred Hutchinson Cancer Center | 1999-06-01 |
| Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome (NCT00003959) | Memorial Sloan Kettering Cancer Center | 1999-06-01 |
| Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy (NCT00006220) | Washington University School of Medicine | 1999-06-01 |
| R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia (NCT00004009) | University of Maryland, Baltimore | 1999-06-01 |
| Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00005092) | M.D. Anderson Cancer Center | 1999-05-28 |
| Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia (NCT00015873) | Dutch Childhood Oncology Group | 1999-05-01 |
| Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer (NCT00004061) | Memorial Sloan Kettering Cancer Center | 1999-05-01 |
| Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome (NCT00003961) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1999-04-01 |
| Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia (NCT00003933) | Children's Oncology Group | 1999-04-01 |
| Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia (NCT00003861) | Alliance for Clinical Trials in Oncology | 1999-04-01 |
| S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer (NCT00919425) | SWOG Cancer Research Network | 1999-04-01 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia (NCT00008190) | Herbert Irving Comprehensive Cancer Center | 1999-03-01 |
| Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia (NCT00003783) | Children's Oncology Group | 1999-03-01 |
| Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia (NCT00003727) | University of Maryland, Baltimore | 1999-03-01 |
| Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant (NCT00530218) | City of Hope Medical Center | 1999-03-01 |
| Topotecan in Treating Patients With Myelodysplastic Syndrome (NCT00003675) | Alliance for Clinical Trials in Oncology | 1999-03-01 |
| Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia (NCT00004052) | Memorial Sloan Kettering Cancer Center | 1999-03-01 |
| Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia (NCT00003870) | Fred Hutchinson Cancer Center | 1999-02-01 |
| Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia (NCT00003931) | Alliance for Clinical Trials in Oncology | 1999-02-01 |
| Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia (NCT00003874) | Fred Hutchinson Cancer Center | 1999-02-01 |
| Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia (NCT00054171) | Roswell Park Cancer Institute | 1999-02-01 |
| WT1 for the Detection of Minimal Residual Disease (NCT00179829) | Ann & Robert H Lurie Children's Hospital of Chicago | 1999-02-01 |
| Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia (NCT00003868) | Fred Hutchinson Cancer Center | 1999-02-01 |
| Clofarabine in Chronic Lymphocytic Leukemia (NCT00028418) | M.D. Anderson Cancer Center | 1999-02-01 |
| Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia (NCT00003700) | Alliance for Clinical Trials in Oncology | 1999-01-01 |
| Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome (NCT00003827) | ALZA | 1999-01-01 |
| 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents (NCT00003635) | GlaxoSmithKline | 1999-01-01 |
| Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00003402) | University of Maryland, Baltimore | 1999-01-01 |
| Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer (NCT00296023) | University of California, San Francisco | 1999-01-01 |
| Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT00053131) | Roswell Park Cancer Institute | 1999-01-01 |
| Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia (NCT00003693) | M.D. Anderson Cancer Center | 1998-12-18 |
| Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial (NCT01004640) | Alliance for Clinical Trials in Oncology | 1998-12-15 |
| Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy (NCT00003600) | Alliance for Clinical Trials in Oncology | 1998-12-01 |
| Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant (NCT00107354) | Fred Hutchinson Cancer Center | 1998-12-01 |
| Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma (NCT00003728) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-12-01 |
| Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease (NCT00003913) | Fred Hutchinson Cancer Center | 1998-12-01 |
| Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia (NCT00003735) | Children's Oncology Group | 1998-12-01 |
| Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia (NCT00003729) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-12-01 |
| Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00005823) | Leukemia Research Fund | 1998-12-01 |
| 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder (NCT00004058) | University of Medicine and Dentistry of New Jersey | 1998-12-01 |
| Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia (NCT00003758) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-12-01 |
| Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia (NCT00003671) | Children's Oncology Group | 1998-12-01 |
| Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma (NCT00003793) | Children's Oncology Group | 1998-12-01 |
| Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia (NCT00021983) | National Cancer Institute (NCI) | 1998-12-01 |
| Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004145) | University of Chicago | 1998-11-01 |
| Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia (NCT00008697) | Washington University School of Medicine | 1998-11-01 |
| Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer (NCT00003816) | Roswell Park Cancer Institute | 1998-10-19 |
| Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma (NCT00005580) | Virginia Commonwealth University | 1998-09-01 |
| Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome (NCT00005593) | Case Comprehensive Cancer Center | 1998-09-01 |
| Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers (NCT00003658) | Memorial Sloan Kettering Cancer Center | 1998-09-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00004105) | NYU Langone Health | 1998-09-01 |
| Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia (NCT00003746) | Swiss Cancer Institute | 1998-09-01 |
| Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia (NCT00003659) | Memorial Sloan Kettering Cancer Center | 1998-09-01 |
| Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome (NCT00003415) | University of Arizona | 1998-09-01 |
| Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00003396) | University of Maryland, Baltimore | 1998-09-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00003398) | University of Maryland, Baltimore | 1998-09-01 |
| Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia (NCT00005863) | Medical Research Council | 1998-08-01 |
| Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers (NCT00003572) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-08-01 |
| Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation (NCT00003887) | Fred Hutchinson Cancer Center | 1998-08-01 |
| 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT00003545) | National Cancer Institute (NCI) | 1998-08-01 |
| Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases (NCT00003662) | Roswell Park Cancer Institute | 1998-08-01 |
| Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia (NCT00083694) | University of Arkansas | 1998-08-01 |
| Use of Topotecan in Patients With Refractory Acute Leukemia (NCT00100477) | US Department of Veterans Affairs | 1998-08-01 |
| Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer (NCT00003451) | National Cancer Institute (NCI) | 1998-08-01 |
| Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome (NCT00047268) | European Working Group of MDS in Childhood | 1998-07-01 |
| Protection Against Benzene Toxicity (NCT00011453) | National Institute of Environmental Health Sciences (NIEHS) | 1998-07-01 |
| Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia (NCT00003436) | Medical Research Council | 1998-07-01 |
| Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia (NCT00003991) | Maxim Pharmaceuticals | 1998-07-01 |
| Treatment for Chronic Pain in Patients With Advanced Cancer (NCT00003687) | NCIC Clinical Trials Group | 1998-06-11 |
| UCN-01 in Treating Patients With Advanced Cancer (NCT00003289) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-06-01 |
| Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission (NCT00899899) | Children's Oncology Group | 1998-06-01 |
| Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia (NCT00005579) | University of Vermont | 1998-06-01 |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer (NCT00003661) | Roswell Park Cancer Institute | 1998-06-01 |
| Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy (NCT00004040) | Hoag Memorial Hospital Presbyterian | 1998-06-01 |
| Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia (NCT00011934) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-05-01 |
| Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia (NCT00003174) | Barbara Ann Karmanos Cancer Institute | 1998-05-01 |
| Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer (NCT00003435) | Duke University | 1998-05-01 |
| Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome (NCT00003171) | Barbara Ann Karmanos Cancer Institute | 1998-05-01 |
| Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer (NCT00003395) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders (NCT00008307) | Herbert Irving Comprehensive Cancer Center | 1998-04-01 |
| Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00003962) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-04-01 |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia (NCT00003405) | Rush University Medical Center | 1998-04-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia (NCT00004084) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 1998-04-01 |
| Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (NCT00003408) | Cancer Treatment Centers of America | 1998-04-01 |
| Decitabine in Treating Patients With Myelodysplastic Syndrome (NCT00003361) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00003960) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-04-01 |
| Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases (NCT00001686) | National Cancer Institute (NCI) | 1998-03-19 |
| CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse (NCT00003673) | Pfizer | 1998-03-01 |
| Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia (NCT00009698) | Children's Oncology Group | 1998-03-01 |
| Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia (NCT00003248) | Alliance for Clinical Trials in Oncology | 1998-03-01 |
| Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia (NCT00003178) | Children's Oncology Group | 1998-03-01 |
| Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia (NCT00003217) | Children's Oncology Group | 1998-03-01 |
| 2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES) (NCT00483067) | M.D. Anderson Cancer Center | 1998-03-01 |
| Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia (NCT00003291) | Children's Oncology Group | 1998-03-01 |
| Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia (NCT00003602) | Riverside Haematology Group | 1998-03-01 |
| Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia (NCT00003239) | M.D. Anderson Cancer Center | 1998-03-01 |
| Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia (NCT00003619) | Drexel University College of Medicine | 1998-02-01 |